$ALLE

Allegion raises 2026 adjusted EPS outlook to $9.05-$9.10 as Americas non-residential momentum continues (NYSE:ALLE)

Allegion (ALLE) reported Q3 2026 results with strong organic growth in Americas, led by double-digit growth in Non-Residential. CEO John Stone attributed this to momentum in the sector. The company raised its 2026 adjusted EPS outlook to $9.05-$9.10. International business resolved ERP issues.

Original reporting
Published Oct 22, 2026, 2:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 3:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ALLE
Bullish
high confidence
Mentioned
$ALLE
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$ALLEBullishMed
01

Why it matters

The EPS outlook lift signals better-than-expected performance, likely prompting a short‑term price rally.

02

Market read

Guidance upgrade is a primary catalyst for Allegion's stock, offering a clear trading opportunity.

03

What to watch

Potential supply‑chain constraints in the Americas could temper the earnings upside.

Relevance 7/10Novelty 7/10Timing: today

Background

Allegion (NYSE:ALLE) is a global provider of security products. The company reported strong organic growth in its Americas non‑residential segment.

Company-level read

Ticker impact

$ALLEBullishHigh confidence
Context

Allegion raised its 2026 adjusted EPS outlook to $9.05‑$9.10, indicating stronger earnings expectations.

Expected impact

potential upside as investors price in higher earnings expectations

Evidence & confidence

EPS outlook lift is a fresh, material piece of information that can move the stock.

Market effects

Higher EPS guidance may boost sentiment in the security hardware sector.

U.S. investors may view Allegion more favorably, modestly supporting broader industrial stocks.

Limited to U.S. equities; no direct global impact.

Counterpoint

If the outlook raise reflects a one‑time cost saving, the boost could be temporary.

Key entities

  • Allegion

    Security solutions provider raising 2026 EPS guidance.

Related articles

$ALLEHigh

BofA upgrades Allegion stock rating on strong earnings outlook

BofA upgraded Allegion (ALLE) to Buy, raising its price target to $200. The stock rose to $176.52. The upgrade follows strong Q3 2026 earnings and raised guidance, with BofA citing accelerated Americas growth. Earnings per share estimates were increased for 2026-2028. Allegion reported Q3 EPS of $2.60 and revenue of $1.17 billion, both exceeding expectations.

$ALLEMed

Allegion PLC (ALLE) (Q3 2026) Earnings Call Highlights: Raised Full-Year Outlook

Allegion PLC (ALLE) reported Q3 2026 earnings, raising its full-year outlook despite challenges. International segment revenue declined slightly, with weak Western Europe performance. The company expects persistent inflation into 2027, requiring continued pricing actions. Americas non-residential segment grew high single digits, driven by volume and price. CEO John Stone expressed confidence in the Schlage brand and its integration with smart home providers.

$ALLEHigh

Allegion (ALLE) Q3 2026 Earnings Call Transcript

Allegion (ALLE) reported Q3 2026 revenue of $1.2B, up 9.6% YoY, with organic growth of 7.2%. The company raised its full-year revenue outlook to 9.5-10.5% and EPS to $9.05-$9.10, driven by strong Americas performance. It completed the $90M acquisition of Overly Door Company and invested $40M in Ambient.ai. Q3 EPS was $2.60, up 13% YoY. International segment saw slight organic decline due to Western Europe weakness.

$ALLEHighAI 8/10

Why Allegion (ALLE) stock is up today

Allegion (ALLE) shares rose 6.9% after reporting Q3 2026 results with high-single digit organic revenue growth and low-teens adjusted EPS growth. The company raised its full-year adjusted EPS guidance to $9.08 at the midpoint. Performance was driven by gains in its Americas non-residential unit, with solid organic growth and double-digit adjusted profit expansion. The stock is up 7% YTD and trading near its 52-week high.